WDR4 gene polymorphisms increase hepatoblastoma susceptibility in girls

Shaohua He,Jinhong Zhu,Zhixiang Xiao,Jiabin Liu,Jiao Zhang,Yong Li,Zhonghua Yang,Jiwen Cheng,Suhong Li,Li Li,Jing He,Di Xu
DOI: https://doi.org/10.7150/jca.76255
IF: 3.9
2022-01-01
Journal of Cancer
Abstract:Hepatoblastoma, originating from hepatoblasts, is the most common hepatic malignancy. WD repeat domain 4 (WDR4) is a subunit of RNA N(7)-methylguanine (m7G) methyltransferase complex. Recently, WDR4 has shown oncogenic potential in various adult cancers, but its roles in pediatric cancers have not been reported. We performed a case-control study (313 cases vs. 1446 controls) to investigate whether genetic variants in the <i>WDR4</i> gene influence hepatoblastoma susceptibility in the Chinese Han nationality. We first determine the genotypes of five <i>WDR4</i> gene polymorphisms (rs2156315 C&gt;T, rs2156316 C&gt;G, rs6586250 C&gt;T, rs15736 G&gt;A, rs2248490 C&gt;G) in participants, using the Taqman assay. And then, an unconditional logistic regression analysis was performed to assess the association between <i>WDR4</i> gene polymorphisms and hepatoblastoma risk. Overall, we did not find any polymorphism significantly associated with the risk of developing hepatoblastoma. Instead, the stratified analysis revealed that the co-existence of 2-5 risk genotypes increased hepatoblastoma risk by 2.23 folds in girls (adjusted odds ratio=2.23, 95% confidence interval=1.17-4.23, <i>P</i>=0.014). In conclusion, our results demonstrate that single selected polymorphisms were too weak to exert a significant effect on the whole study population. However, in combination, two or more <i>WDR4</i> gene polymorphisms significantly conferred increased hepatoblastoma risk in girls. Our findings may encourage more genetic association studies to discover significant polymorphisms in the <i>WDR4</i> gene for hepatoblastoma.
oncology
What problem does this paper attempt to address?